In vivo imaging of HIF-active tumors by an oxygen-dependent degradation protein probe with an interchangeable labeling system.
about
Flavin mononucleotide-based fluorescent proteins function in mammalian cells without oxygen requirementHaloTag technology: a versatile platform for biomedical applicationsIn vivo imaging of brain ischemia using an oxygen-dependent degradative fusion protein probeMolecular imaging in pancreatic cancer--a roadmap for therapeutic decisions.Novel molecular and nanosensors for in vivo sensingA fluorescent protein scaffold for presenting structurally constrained peptides provides an effective screening system to identify high affinity target-binding peptides.Detection of the onset of ischemia and carcinogenesis by hypoxia-inducible transcription factor-based in vivo bioluminescence imagingImaging molecular dynamics in vivo--from cell biology to animal models.The effect of triamcinolone acetonide on laser-induced choroidal neovascularization in mice using a hypoxia visualization bio-imaging probe.In vivo visualization of heterogeneous intratumoral distribution of hypoxia-inducible factor-1α activity by the fusion of high-resolution SPECT and morphological imaging tests.Curb challenges of the "Trojan Horse" approach: smart strategies in achieving effective yet safe cell-penetrating peptide-based drug delivery.A novel injectable BRET-based in vivo imaging probe for detecting the activity of hypoxia-inducible factor regulated by the ubiquitin-proteasome systemHypoxia-Sensitive Materials for Biomedical Applications.Lipocalin2 as a plasma marker for tumors with hypoxic regions.Development of an oxygen-sensitive degradable peptide probe for the imaging of hypoxia-inducible factor-1-active regions in tumors.Chemical Methodology for Labelling and BioconjugationSynthesis and biological activity of furanylindazoles as inhibitors of hypoxia inducible factor (HIF)-1 transcriptional activity
P2860
Q21134070-B3A7C239-05F0-4057-BAE7-D81280B1E931Q26997400-E6A62AA8-EDB6-4A9E-A0D4-D1DBD125FDB2Q28484495-E61ABDC3-8D10-419C-9371-F2BD31E01451Q30423854-E3A0B67B-E635-4AC6-8C3B-D76EB83922FDQ30450856-F6975F70-8815-4CA4-ABFF-27A79B507ABBQ33989074-77B3EF36-0790-47B5-AB43-1A458E17C896Q34079232-91DA1230-1CF7-4BF3-810F-C0BF121935C8Q34211941-93199528-D7A9-4CAA-9514-62B1084C9CFDQ35618569-A0DE5076-B58D-4156-ACDC-9E068B43483DQ36063742-A529563E-3772-4159-95C9-17C53EDE62B6Q36854231-07B76A54-224B-4CC3-84CF-31C3D21C287DQ37307621-55EB26AE-81B3-4A8C-A9A4-0B565620E1AEQ38754932-612E5C09-7D1A-483D-BE15-13E34DDFF552Q38932870-E1B7F6AE-3138-4FC1-87BD-8ED0BB82C2FFQ39149491-E3DB7448-8378-4CD2-86AE-D496C3EA2DA4Q57341130-F2B94C36-5496-418C-98DD-9318B143DDC9Q58615248-EDA0FA67-4553-4A66-8EC4-8D2B9C4C8032
P2860
In vivo imaging of HIF-active tumors by an oxygen-dependent degradation protein probe with an interchangeable labeling system.
description
2010 nî lūn-bûn
@nan
2010 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
In vivo imaging of HIF-active ...... terchangeable labeling system.
@ast
In vivo imaging of HIF-active ...... terchangeable labeling system.
@en
type
label
In vivo imaging of HIF-active ...... terchangeable labeling system.
@ast
In vivo imaging of HIF-active ...... terchangeable labeling system.
@en
prefLabel
In vivo imaging of HIF-active ...... terchangeable labeling system.
@ast
In vivo imaging of HIF-active ...... terchangeable labeling system.
@en
P2093
P2860
P1433
P1476
In vivo imaging of HIF-active ...... terchangeable labeling system.
@en
P2093
Masahiro Hiraoka
Shotaro Tanaka
Takashi Ushiki
Tetsuya Kadonosono
P2860
P304
P356
10.1371/JOURNAL.PONE.0015736
P407
P577
2010-12-23T00:00:00Z